1 |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394. |
2 |
Rubenstein JH, Shaheen NJ. Epidemiology, diagnosis, and management of esophageal adenocarcinoma[J]. Gastroenterology, 2015, 149(2): 302. |
3 |
Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma[J]. Lancet, 2013, 381(9864): 400. |
4 |
Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer[J]. Ann Thorac Surg, 2003, 76(4): S1367. |
5 |
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2): 74. |
6 |
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023. |
7 |
Ji X, Cai J, Chen Y, et al. Lymphatic spreading and lymphadenectomy for esophageal carcinoma[J]. World J Gastrointest Surg, 2016, 8(1): 90. |
8 |
Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration[J]. Dis Esophagus, 2009, 22(1): 1. |
9 |
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008, 58(2): 71. |
10 |
Hafizi S, Dahlbäck B. Gas6 and protein S. vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily[J]. FEBS J, 2006, 273(23): 5231. |
11 |
Lee HJ, Jeng YM, Chen YL, et al. Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of slug in hepatocellular carcinoma[J]. Carcinogenesis, 2014, 35(4): 769. |
12 |
Gjerdrum C, Tiron C, Høiby T, et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival[J]. Proc Natl Acad Sci U S A, 2010, 107(3): 1124. |
13 |
Kim JE, Leung E, Baguley BC, et al. Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines[J]. Front Genet, 2013, 4: 97. |
14 |
Li JX, Dai CY, Shen L. Ursolic acid inhibits epithelial-mesenchymal transition through the Axl/NF-κB pathway in gastric cancer cells[J]. Evid Based Complement Alternat Med, 2019, 2019: 2474805. |
15 |
Yang YC, Huang XZ, Zhou LK, et al. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma[J]. BMC Cancer, 2019, 19(1): 526. |
16 |
Shimada H, Nakajima K, Ochiai T, et al. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers[J]. Oncol Rep, 1998, 5(4): 871. |
17 |
孔令玉.启膈方调控Gas6/Axl信号传导通路抑制食管癌细胞迁移和侵袭的研究[D].石家庄:河北医科大学, 2020. |
18 |
Alayev A, Berger SM, Kramer MY, et al. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells[J]. J Cell Biochem, 2015, 116(3): 450. |
19 |
Gorris MAJ, Halilovic A, Rabold K, et al. Eight-color multiplex immunohistochemistry for simultaneous detection of multiple immune checkpoint molecules within the tumor microenvironment[J]. J Immunol, 2018, 200(1): 347. |
20 |
Kong LY, Wu ZB, Zhao Y, et al. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression[J]. Biosci Rep, 2019, 39(6): BSR20190850. |
21 |
Mullen M M, Lomonosova E, Toboni M D, et al. Inducing 'BRCAness' by inhibiting the GAS6/AXL pathway in high-grade serous ovarian cancer[J]. Gynecol Oncol, 2020, 159(Suppl-1): 137. |
22 |
Kong LY, Lu X, Chen XY, et al. Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition[J]. Aging (Albany NY), 2020, 12(10): 9714. |
23 |
Wimmel A, Glitz D, Kraus A, et al. Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion[J]. Eur J Cancer, 2001, 37(17): 2264. |
24 |
Rankin EB, Fuh KC, Castellini L, et al. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET[J]. Proc Natl Acad Sci U S A, 2014, 111(37): 13373. |
25 |
Goyette MA, Duhamel S, Aubert L, et al. The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression[J]. Cell Rep, 2018, 23(5): 1476. |
26 |
Revach OY, Sandler O, Samuels Y, et al. Cross-talk between receptor tyrosine kinases AXL and ERBB3 regulates invadopodia formation in melanoma cells[J]. Cancer Res, 2019, 79(10): 2634. |
27 |
史会娟, 薛健雄, 石冬璇, 等. 以“甘润濡养”立法的启膈方抑制裸鼠食管癌肺转移的研究[J]. 中国全科医学, 2018, 21(27): 3373. |